Lauren Aoude

Employment

• University of Queensland Research Fellow

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (43)

• GOLM1: expanding our understanding of melanoma susceptibility
  Journal of Medical Genetics 2023 DOI: 10.1136/jmg-2023-109348
  +Save
• Data from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.c.6545076.v1
  +Save
• Data from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.c.6545076
  +Save
• Supplementary Figure 1 from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.22526397
  +Save
• Supplementary Figure 1 from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.22526397.v1
  +Save
• Supplementary Figure 2 from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.22526394
  +Save
• Supplementary Figure 2 from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.22526394.v1
  +Save
• Supplementary Figure 3 from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.22526391
  +Save
• Supplementary Figure 3 from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.22526391.v1
  +Save
• Supplementary Tables 1-4 from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.22526388
  +Save
• Supplementary Tables 1-4 from Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  2023 DOI: 10.1158/1541-7786.22526388.v1
  +Save
• Radiomics biomarkers are associated with survival in patients with Oesophageal Adenocarcinoma
  2023 DOI: 10.21203/rs.3.rs-2684818/v1
  +Save
• Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.
  Priya Ramarao-Milne, Olga Kondrashova, AM Patch +34 more
  ESMO open 2022 DOI: 10.1016/j.esmoop.2022.100540
  +Save
• Unusual suspects in hereditary melanoma: POT1, POLE, BAP1.
  Trends in genetics : TIG 2022 DOI: 10.1016/j.tig.2022.06.007
  +Save
• ctDNA as a biomarker of progression in oesophageal adenocarcinoma.
  Vanessa Bonazzi, Lauren G. Aoude, Sandra Brosda +8 more
  ESMO open 2022 DOI: 10.1016/j.esmoop.2022.100452
  +Save
• Characterizing the Heterogeneity of Small Extracellular Vesicle Populations in Multiple Cancer Types via an Ultrasensitive Chip.
  Jing Wang, Alain Wuethrich, Richard J. Lobb +13 more
  ACS sensors 2021 DOI: 10.1021/acssensors.1c00358
  +Save
• Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients
  Lauren G. Aoude, Bernadette Z.Y. Wong, Vanessa Bonazzi +18 more
  Molecular Cancer Research 2021 DOI: 10.1158/1541-7786.MCR-20-1038
  +Save
• Multiplex melanoma families are enriched for polygenic risk
  Human Molecular Genetics 2020 DOI: 10.1093/hmg/ddaa156
  +Save
• Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients.
  Lauren G. Aoude, Vanessa Bonazzi, Sandra Brosda +12 more
  Scientific reports 2020 DOI: 10.1038/s41598-020-74956-3
  +Save
• EZH2 cooperates with DNA methylation to downregulate key tumour suppressors and interferon gene signatures in melanoma.
  Jessamy C. Tiffen, Stuart J. Gallagher, Fabian V. Filipp +10 more
  The Journal of investigative dermatology 2020 DOI: 10.1016/j.jid.2020.02.042
  +Save